Flexion announces publication of data from repeat administration trial of ZILRETTA®
Flexion announced the results from an open-label Phase 3b clinical trial evaluating safety and exploratory efficacy of repeat administration of ZILRETTA (triamcinolone acetonide extended-release injectable suspension) in patients OA of the knee were published in Rheumatology and Therapy. February 11, 2019